RESEARCH ALERT - Pharmacia & Upjohn raised.

-- Deutsche Morgan Grenfell analyst Mariola Haggar said in a research note that the firm raised Pharmacia & Upjohn to buy from accumulate on positive results on Detrusitol, which is tolterodine, a compound for treatment of incontinence. Regulatory approval is estimated for early 1998.

-- The company provided a preliminary sketch of Phase III results, which in general were positive, Haggar said.

-- Shares were off 1/2 to 38-1/8 in morning New York Stock Exchange trade.

